Garvan's medical research will transform healthcare. We explore the full spectrum of disease so that everyone can live longer and healthier lives.
Translating breakthrough research into precision medicine.
Our greatest strength lies in the exceptional talent and dedication of our people, who are at the forefront of medical research and innovation.
A hub for breaking news, event updates, podcasts and essential resources on human health and disease.
Our mission is to harness the information encoded in our genome to better diagnose, treat, predict and prevent disease.
Our research relies on the generous support of people like you. Show your support for breakthrough medical research today
Garvan drives a number of collaborative programs with scientific and medical institutes globally.
The Clinical Immunogenomics Research Consortium Australasia uses genomics to inform diagnosis and treatment for complex immunological diseases
A multidisciplinary team investigating the link between MS and the Epstein-Barr virus.
A five-year, international collaborative program for Parkinson’s disease, integrating clinical trials with potentially transformative genomic analysis and biomarkers research.
A radical program to understand autoimmune disease. Our researchers think there may be a common cause to type 1 diabetes, multiple sclerosis, lupus and rheumatoid arthritis.
A collaborative study of those who have exceptional responses to cancer treatment — and using this knowledge to help others with the disease.
This program is dedicated to using genomics to improve the understanding, early detection, prevention and management of cancer.
AVaTAR is a unique translational consortium to provide improved, rapid pre-clinical vaccine candidate evaluation.